scholarly article | Q13442814 |
P356 | DOI | 10.1159/000087238 |
P698 | PubMed publication ID | 16037693 |
P50 | author | Ovidio Bussolati | Q39567960 |
Amelia Barilli | Q39993547 | ||
Bianca Maria Rotoli | Q124178628 | ||
P2093 | author name string | Rita Gatti | |
Gian C Gazzola | |||
Valeria Dall'Asta | |||
Guido Orlandini | |||
Jacopo Uggeri | |||
Rossana Visigalli | |||
P2860 | cites work | Stem cells, cancer, and cancer stem cells | Q27860878 |
Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays | Q28140044 | ||
Wnt signaling in B-cell neoplasia | Q28182311 | ||
Asparagine synthetase expression alone is sufficient to induce l-asparaginase resistance in MOLT-4 human leukaemia cells | Q28367265 | ||
Establishment of real-time polymerase chain reaction method for quantitative analysis of asparagine synthetase expression | Q35790343 | ||
Activation of the Wnt signaling pathway in chronic lymphocytic leukemia | Q36854046 | ||
Translocation products in acute myeloid leukemia activate the Wnt signaling pathway in hematopoietic cells. | Q38343552 | ||
A modified radioisotopic assay for measuring glutamine synthetase activity in tissue extracts | Q39261130 | ||
Rapid induction of the intrinsic apoptotic pathway by L-glutamine starvation | Q40511549 | ||
Comparison of annexin V and calcein-AM as early vital markers of apoptosis in adherent cells by confocal laser microscopy. | Q41023441 | ||
Glutamine regulates glutamine synthetase expression in skeletal muscle cells in culture | Q41717087 | ||
Molecular and genetic characterization of human cell lines resistant to L-asparaginase and albizziin | Q41756370 | ||
A splice variant acquiring an extra transcript leader region decreases the translation of glutamine synthetase gene | Q42157146 | ||
Characterization of apoptotic phenomena induced by treatment with L-asparaginase in NIH3T3 cells. | Q42824095 | ||
Suppression of anionic amino acid transport impairs the maintenance of intracellular glutamate in Ha-ras-expressing cells | Q42826665 | ||
Glutamine deprivation-mediated cell shrinkage induces ligand-independent CD95 receptor signaling and apoptosis | Q43765047 | ||
Sensitivity to L-asparaginase is not associated with expression levels of asparagine synthetase in t(12;21)+ pediatric ALL. | Q44217783 | ||
New targets of beta-catenin signaling in the liver are involved in the glutamine metabolism | Q44226601 | ||
Upstream and intronic regulatory sequences interact in the activation of the glutamine synthetase promoter | Q44328134 | ||
Upregulation of asparagine synthetase fails to avert cell cycle arrest induced by L-asparaginase in TEL/AML1-positive leukaemic cells. | Q44729078 | ||
Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment | Q45007602 | ||
A silencer element in the regulatory region of glutamine synthetase controls cell type-specific repression of gene induction by glucocorticoids | Q47973727 | ||
Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine | Q56879285 | ||
P433 | issue | 6 | |
P304 | page(s) | 281-292 | |
P577 | publication date | 2005-01-01 | |
P1433 | published in | Cellular Physiology and Biochemistry | Q2229420 |
P1476 | title | Inhibition of glutamine synthetase triggers apoptosis in asparaginase-resistant cells | |
P478 | volume | 15 |
Q61799801 | Assessment of l-Asparaginase Pharmacodynamics in Mouse Models of Cancer |
Q41427021 | Binding of nickel to testicular glutamate-ammonia ligase inhibits its enzymatic activity |
Q26775475 | Cancer metabolism and oxidative stress: Insights into carcinogenesis and chemotherapy via the non-dihydrofolate reductase effects of methotrexate |
Q36944183 | Cell volume regulatory ion channels in cell proliferation and cell death |
Q33749811 | Cell-cycle inhibition by Helicobacter pylori L-asparaginase |
Q38915906 | Differential mechanisms of asparaginase resistance in B-type acute lymphoblastic leukemia and malignant natural killer cell lines |
Q38657061 | Drug-induced amino acid deprivation as strategy for cancer therapy |
Q38970692 | Glutamine depletion by crisantaspase hinders the growth of human hepatocellular carcinoma xenografts |
Q54512482 | Glutamine stimulates mTORC1 independent of the cell content of essential amino acids. |
Q24318220 | Glutamine synthetase is essential for proliferation of fetal skin fibroblasts |
Q31043770 | Inborn error of amino acid synthesis: human glutamine synthetase deficiency |
Q37311260 | Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia. |
Q36345950 | Ion channels in cell proliferation and apoptotic cell death |
Q46518378 | Pharmacokinetic, pharmacodynamic and intracellular effects of PEG-asparaginase in newly diagnosed childhood acute lymphoblastic leukemia: results from a single agent window study |
Q38994917 | Pharmacology, immunogenicity, and efficacy of a novel pegylated recombinant Erwinia chrysanthemi-derived L-asparaginase |
Q46979018 | Reduced Ca2+ entry and suicidal death of erythrocytes in PDK1 hypomorphic mice |
Q54457075 | Role of glutamine depletion in directing tissue-specific nutrient stress responses to L-asparaginase. |
Q38110755 | Role of ion transport in control of apoptotic cell death |
Q30497031 | The eIF2 Kinase GCN2 Is Essential for the Murine Immune System to Adapt to Amino Acid Deprivation by Asparaginase |
Q37341948 | The eukaryotic initiation factor 2 kinase GCN2 protects against hepatotoxicity during asparaginase treatment. |
Q54573293 | The non-proteinogenic amino acids L-methionine sulfoximine and DL-phosphinothricin activate mTOR. |
Q87924791 | [Expression of asparagine synthetase in relapsed or refractory extranodal NK/T cell lymphoma] |
Search more.